BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21493132)

  • 21. Augmentation in restless legs syndrome is associated with low ferritin.
    Trenkwalder C; Högl B; Benes H; Kohnen R
    Sleep Med; 2008 Jul; 9(5):572-4. PubMed ID: 17921065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Restless legs: recent advances in basic research and therapy].
    Sieb JP
    Med Monatsschr Pharm; 2010 Apr; 33(4):133-9. PubMed ID: 20429403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
    Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
    Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.
    Takahashi M; Nishida S; Nakamura M; Kobayashi M; Matsui K; Ito E; Usui A; Inoue Y
    PLoS One; 2017; 12(3):e0173535. PubMed ID: 28264052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of pergolide in the treatment of restless legs syndrome.
    Stiasny K; Wetter TC; Winkelmann J; Brandenburg U; Penzel T; Rubin M; Hundemer HP; Oertel WH; Trenkwalder C
    Neurology; 2001 May; 56(10):1399-402. PubMed ID: 11376198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
    Bares M; Rektorová I; Krajcovicová L; Rektor I
    J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ropinirole treatment of restless legs].
    Kinge E; Lossius MI; Mowincel P
    Ugeskr Laeger; 2005 Mar; 167(11):1284-6. PubMed ID: 15830500
    [No Abstract]   [Full Text] [Related]  

  • 30. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
    Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
    Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 32. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
    Molokwu OC
    Ann Pharmacother; 2008 May; 42(5):627-32. PubMed ID: 18381842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome.
    Vetrugno R; Contin M; Baruzzi A; Provini F; Plazzi G; Montagna P
    Mov Disord; 2006 Feb; 21(2):254-8. PubMed ID: 16200540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
    Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
    Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ropinirole (Requip) for restless legs syndrome.
    Obstet Gynecol; 2006 Jan; 107(1):176-8. PubMed ID: 16394057
    [No Abstract]   [Full Text] [Related]  

  • 36. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.
    Högl B; Kiechl S; Willeit J; Saletu M; Frauscher B; Seppi K; Müller J; Rungger G; Gasperi A; Wenning G; Poewe W
    Neurology; 2005 Jun; 64(11):1920-4. PubMed ID: 15955944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valvular heart disease associated with taking low-dose pergolide for restless legs syndrome.
    Worthington A; Thomas L
    Eur J Echocardiogr; 2008 Nov; 9(6):828-30. PubMed ID: 18579494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.
    Prescrire Int; 2007 Feb; 16(87):12. PubMed ID: 17323517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS.
    Chokroverty S
    Sleep Med; 2015 Oct; 16(10):1304. PubMed ID: 26386895
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sleep and sleep disorders in the elderly: Part 3: Restless legs syndrome].
    Frohnhofen H; Schlitzer J
    Z Gerontol Geriatr; 2015 Jun; 48(4):379-87; quiz 388. PubMed ID: 26025498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.